Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer
Seminars in Liver Disease · 2025-03 · 45 (01) · 033-051
DOI: 10.1055/a-2551-0724 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 29.03.2025. Verfasst von Laura Sererols-Viñas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Microenvironment Plasticity and Heterogeneity Research Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Sp…. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Liver Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Research Council, Agencia Estatal de Investigación, American Cancer Society.
Abstract (Originalsprache)
Hepatic stellate cells (HSCs) are the liver's pericytes, and play key roles in liver homeostasis, regeneration, fibrosis, and cancer. Upon injury, HSCs activate and are the main origin of myofibroblasts and cancer-associated fibroblasts (CAFs) in liver fibrosis and cancer. Primary liver cancer has a grim prognosis, ranking as the third leading cause of cancer-related deaths worldwide, with hepatocellular carcinoma (HCC) being the predominant type, followed by intrahepatic cholangiocarcinoma (iCCA). Moreover, the liver hosts 35% of all metastatic lesions. The distinct spatial distribution and functional roles of HSCs across these malignancies represent a significant challenge for universal therapeutic strategies, requiring a nuanced and tailored understanding of their contributions. This review examines the heterogeneous roles of HSCs in liver cancer, focusing on their spatial localization, dynamic interactions within the tumor microenvironment (TME), and emerging therapeutic opportunities, including strategies to modulate their activity, and harness their potential as targets for antifibrotic and antitumor interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Tumor Microenvironment Plasticity and Heterogeneity Research Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
- University of Barcelona, Barcelona, Spain.
- Tissue Remodeling Fibrosis and Cancer Group, Institute of Biomedical Research of Barcelona, Spanish National Research Council, Barcelona, Spain.
- Institute of Biomedical Research of Barcelona (IDIBAPS), Barcelona, Spain.
- CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, Instituto de Salud Carlos III, Madrid, Spain.
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Förderung
- European Research Council
- Agencia Estatal de Investigación
- American Cancer Society
- NCI NIH HHS
- NIDDK NIH HHS
- Pfizer Foundation
- NIH HHS
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
Zitieren
APA
Sererols-Viñas, L., Garcia-Vicién, G., Ruiz-Blázquez, P., Lee, T. F., Lee, Y. A., Gonzalez-Sanchez, E., Vaquero, J., Moles, A., Filliol, A., & Affò, S. (2025). Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer. Seminars in Liver Disease, 45(01), 033-051. https://doi.org/10.1055/a-2551-0724
Vancouver
Sererols-Viñas L, Garcia-Vicién G, Ruiz-Blázquez P, Lee TF, Lee YA, Gonzalez-Sanchez E, et al. Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer. Seminars in Liver Disease. 2025;45(01):033-051. doi:10.1055/a-2551-0724
BibTeX
@article{SererolsVias2025,
author = {Sererols-Viñas, Laura and Garcia-Vicién, Gemma and Ruiz-Blázquez, Paloma and Lee, Ting-Fang and Lee, Youngmin A and Gonzalez-Sanchez, Ester and Vaquero, Javier and Moles, Anna and Filliol, Aveline and Affò, Silvia},
title = {Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer},
journal = {Seminars in Liver Disease},
year = {2025},
volume = {45},
number = {01},
pages = {033--051},
doi = {10.1055/a-2551-0724}
}
EUVIMED